Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction

Table 4 Urological malignancy-related adverse events at the end of follow-up

Variable	TURP (n = 736)	Medication (n = 736)	TURP vs. Medication
Variable	TURP (n = 736)	Medication (n = 736)	HR (95% CI)	P value
Prostate adenocarcinoma	18 (2.4)	19 (2.6)	0.79 (0.41, 1.50)	0.463
Bladder urothelial carcinoma	5 (0.7)	10 (1.4)	0.41 (0.14, 1.19)	0.102

Abbreviations: TURP transurethral resection of the prostate, HR hazard ratio, CI confidence interval

ISSN: 1471-2318